This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
With new technologies driving step changes in biopharma, we can help you predict and plan for the next round of disruptive changes.
Charles River Associates has previously assessed the implications of proposals to implement international reference pricing in the US and found they would...
Introduction After multiple delays, the PMPRB (Patented Medicine Prices Review Board) is expected to implement revised guidelines within 2022, which include an...
